The chief executive officer of Likarda discussed the company’s CSS technology and how it may reduce off-tissue effects.
Stella Vnook, PharmD
Advertisement
Articles by Stella Vnook, PharmD
Advertisement
Latest Updated Articles
Stella Vnook, PharmD, on Improving Cell Therapy Delivery to Solid Tumors With Core Shell SpherificationPublished: November 2nd 2023 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
2
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
3
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
4
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
5
